Trial
NCT00702793
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of British Columbia
Collaborators
Provincial Health Services Authority British Columbia
Condition
Schizophrenia
Intervention
Varenicline
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-29